The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Advances in the diagnosis and management of IgG4 related disease
Abstract
IgG4 related disease was recognized as a unified disease entity only 15 years ago. Awareness of IgG4 related disease has increased worldwide since then, and specialists are now familiar with most of its clinical manifestations. Involvement of the pancreato-biliary tract, retroperitoneum/aorta, head and neck, and salivary glands are the most frequently observed disease phenotypes, differing in epidemiological features, serological findings, and prognostic outcomes. In view of this multifaceted presentation, IgG4 related disease represents a great mimicker of many neoplastic, inflammatory, and infectious conditions. Histopathology remains key to diagnosis because reliable biomarkers are lacking. Recently released classification criteria will be invaluable in improving early recognition of the disease. IgG4 related disease is highly treatable and responds promptly to glucocorticoids, but it can lead to end stage organ failure and even death if unrecognized. Prolonged courses of corticosteroids are often needed to maintain remission because the disease relapses in most patients. Rapid advancement in our understanding of the pathophysiology of IgG4 related disease is leading to the identification of novel therapeutic targets and possible personalized approaches to treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Doorenspleet, M. E., Hubers, L. M., Culver, E. L., Wenniger, L. J. M. D. B., Klarenbeek, P. L., Chapman, R. W., Baas, F., van de Graaf, S. F. J., Verheij, J., van Gulik, T. M., et al. (2016) · Hepatology · doi:10.1002/hep.28568 · Cited by 97
RetractedHigh Serum IgG4 Concentrations in Patients with Sclerosing Pancreatitis
Hamano, H., Kawa, S., Horiuchi, A., Unno, H., Furuya, N., Akamatsu, T., Fukushima, M., Nikaido, T., Nakayama, K., Usuda, N., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441005 · Cited by 2,705
Consensus statement on the pathology of IgG4-related disease
Deshpande, V., Zen, Y., Chan, J. K., Yi, E. E., Sato, Y., Yoshino, T., Klöppel, G., Heathcote, J. G., Khosroshahi, A., Ferry, J. A., et al. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.72 · Cited by 2,596
Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011
Umehara, H., Okazaki, K., Masaki, Y., Kawano, M., Yamamoto, M., Saeki, T., Matsui, S., Yoshino, T., Nakamura, S., Kawa, S., et al. (2012) · Modern Rheumatology · doi:10.1007/s10165-011-0571-z · Cited by 2,028
Shimosegawa, T., Chari, S. T., Frulloni, L., Kamisawa, T., Kawa, S., Mino-Kenudson, M., Kim, M.-H., Klöppel, G., Lerch, M. M., Löhr, M., et al. (2011) · Pancreas · doi:10.1097/mpa.0b013e3182142fd2 · Cited by 1,526
International Consensus Guidance Statement on the Management and Treatment of IgG4‐Related Disease
Khosroshahi, A., Wallace, Z. S., Crowe, J. L., Akamizu, T., Azumi, A., Carruthers, M. N., Chari, S. T., Della‐Torre, E., Frulloni, L., Goto, H., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39132 · Cited by 1,064
Self-citationAnti-Inflammatory Activity of Human IgG4 Antibodies by Dynamic Fab Arm Exchange
van der Neut Kolfschoten, M., Schuurman, J., Losen, M., Bleeker, W. K., Martínez-Martínez, P., Vermeulen, E., den Bleker, T. H., Wiegman, L., Vink, T., Aarden, L. A., et al. (2007) · Science · doi:10.1126/science.1144603 · Cited by 975
Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy
Ghazale, A., Chari, S. T., Zhang, L., Smyrk, T. C., Takahashi, N., Levy, M. J., Topazian, M. D., Clain, J. E., Pearson, R. K., Petersen, B. T., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.12.009 · Cited by 890
Immunoglobulin G4: an odd antibody
Aalberse, R. C., Stapel, S. O., Schuurman, J., & Rispens, T. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03207.x · Cited by 818
Wallace, Z. S., Naden, R. P., Chari, S., Choi, H. K., Della-Torre, E., Dicaire, J.-F., Hart, P. A., Inoue, D., Kawano, M., Khosroshahi, A., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216561 · Cited by 755
Self-citationRituximab for IgG4-related disease: a prospective, open-label trial
Carruthers, M. N., Topazian, M. D., Khosroshahi, A., Witzig, T. E., Wallace, Z. S., Hart, P. A., Deshpande, V., Smyrk, T. C., Chari, S., & Stone, J. H. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206605 · Cited by 726
Standard steroid treatment for autoimmune pancreatitis
Kamisawa, T., Shimosegawa, T., Okazaki, K., Nishino, T., Watanabe, H., Kanno, A., Okumura, F., Nishikawa, T., Kobayashi, K., Ichiya, T., et al. (2009) · Gut · doi:10.1136/gut.2008.172908 · Cited by 724
Wallace, Z. S., Naden, R. P., Chari, S., Choi, H., Della‐Torre, E., Dicaire, J., Hart, P. A., Inoue, D., Kawano, M., Khosroshahi, A., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41120 · Cited by 685
Self-citationIgG4‐Related Disease: Clinical and Laboratory Features in One Hundred Twenty‐Five Patients
Wallace, Z. S., Deshpande, V., Mattoo, H., Mahajan, V. S., Kulikova, M., Pillai, S., & Stone, J. H. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39205 · Cited by 666
Zen, Y., Fujii, T., Harada, K., Kawano, M., Yamada, K., Takahira, M., & Nakanuma, Y. (2007) · Hepatology · doi:10.1002/hep.21697 · Cited by 652
Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis
Hart, P. A., Kamisawa, T., Brugge, W. R., Chung, J. B., Culver, E. L., Czakó, L., Frulloni, L., Go, V. L. W., Gress, T. M., Kim, M.-H., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-303617 · Cited by 584
The diagnostic utility of serum IgG4 concentrations in IgG4-related disease
Carruthers, M. N., Khosroshahi, A., Augustin, T., Deshpande, V., & Stone, J. H. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204907 · Cited by 550
Khosroshahi, A., Bloch, D. B., Deshpande, V., & Stone, J. H. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27435 · Cited by 522
Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations
Wallace, Z. S., Mattoo, H., Carruthers, M., Mahajan, V. S., Della Torre, E., Lee, H., Kulikova, M., Deshpande, V., Pillai, S., & Stone, J. H. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205233 · Cited by 494
Self-citationRituximab for the Treatment of IgG4-Related Disease: Lessons From 10 Consecutive Patients
Khosroshahi, A., Carruthers, M. N., Deshpande, V., Unizony, S., Bloch, D. B., & Stone, J. H. (2012) · Medicine · doi:10.1097/md.0b013e3182431ef6 · Cited by 489
Proposal for diagnostic criteria for IgG4-related kidney disease
Kawano, M., Saeki, T., Nakashima, H., Nishi, S., Yamaguchi, Y., Hisano, S., Yamanaka, N., Inoue, D., Yamamoto, M., Takahashi, H., et al. (2011) · Clinical and Experimental Nephrology · doi:10.1007/s10157-011-0521-2 · Cited by 432
Hart, P. A., Topazian, M. D., Witzig, T. E., Clain, J. E., Gleeson, F. C., Klebig, R. R., Levy, M. J., Pearson, R. K., Petersen, B. T., Smyrk, T. C., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-302886 · Cited by 416
Wallace, Z. S., Zhang, Y., Perugino, C. A., Naden, R., Choi, H. K., & Stone, J. H. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-214603 · Cited by 415
Clonal expansion of CD4+ cytotoxic T lymphocytes in patients with IgG4-related disease
Mattoo, H., Mahajan, V. S., Maehara, T., Deshpande, V., Della-Torre, E., Wallace, Z. S., Kulikova, M., Drijvers, J. M., Daccache, J., Carruthers, M. N., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.12.1330 · Cited by 406
Self-citationMattoo, H., Mahajan, V. S., Della-Torre, E., Sekigami, Y., Carruthers, M., Wallace, Z. S., Deshpande, V., Stone, J. H., & Pillai, S. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.03.034 · Cited by 386
Self-citationDiagnosis of IgG4-Related Tubulointerstitial Nephritis
Raissian, Y., Nasr, S. H., Larsen, C. P., Colvin, R. B., Smyrk, T. C., Takahashi, N., Bhalodia, A., Sohani, A. R., Zhang, L., Chari, S., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011010062 · Cited by 374
Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease
Della Torre, E., Mattoo, H., Mahajan, V. S., Carruthers, M., Pillai, S., & Stone, J. H. (2014) · Allergy · doi:10.1111/all.12320 · Cited by 292
Self-citationSato, Y., Kojima, M., Takata, K., Morito, T., Asaoku, H., Takeuchi, T., Mizobuchi, K., Fujihara, M., Kuraoka, K., Nakai, T., et al. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.17 · Cited by 280
Evaluation and Management of Autoimmune Pancreatitis: Experience at a Large US Center
Raina, A., Yadav, D., Krasinskas, A. M., McGrath, K. M., Khalid, A., Sanders, M., Whitcomb, D. C., & Slivka, A. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.325 · Cited by 275
Ebbo, M., Grados, A., Samson, M., Groh, M., Loundou, A., Rigolet, A., Terrier, B., Guillaud, C., Carra-Dallière, C., Renou, F., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0183844 · Cited by 253
International consensus for the treatment of autoimmune pancreatitis
Okazaki, K., Chari, S. T., Frulloni, L., Lerch, M. M., Kamisawa, T., Kawa, S., Kim, M.-H., Lévy, P., Masamune, A., Webster, G., et al. (2017) · Pancreatology · doi:10.1016/j.pan.2016.12.003 · Cited by 249
Characterizing IgG4-related disease with 18F-FDG PET/CT: a prospective cohort study
Zhang, J., Chen, H., Ma, Y., Xiao, Y., Niu, N., Lin, W., Wang, X., Liang, Z., Zhang, F., Li, F., et al. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2729-3 · Cited by 246
Kamisawa, T., Okazaki, K., Kawa, S., Ito, T., Inui, K., Irié, H., Nishino, T., Notohara, K., Nishimori, I., Tanaka, S., et al. (2014) · Journal of Gastroenterology · doi:10.1007/s00535-014-0945-z · Cited by 245
Ebbo, M., Daniel, L., Pavic, M., Sève, P., Hamidou, M., Andres, E., Burtey, S., Chiche, L., Serratrice, J., Longy-Boursier, M., et al. (2012) · Medicine · doi:10.1097/md.0b013e3182433d77 · Cited by 243
Lin, W., Lu, S., Chen, H., Wu, Q., Fei, Y., Li, M., Zhang, X., Tian, X., Zheng, W., Leng, X., et al. (2015) · Rheumatology · doi:10.1093/rheumatology/kev203 · Cited by 240
IgG4-Related Hypertrophic Pachymeningitis: Clinical Features, Diagnostic Criteria, and Treatment
Lu, L. X., Della-Torre, E., Stone, J. H., & Clark, S. W. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.243 · Cited by 238
Self-citationDevelopment of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis
Miloslavsky, E. M., Naden, R. P., Bijlsma, J. W. J., Brogan, P. A., Brown, E. S., Brunetta, P., Buttgereit, F., Choi, H. K., DiCaire, J.-F., Gelfand, J. M., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210002 · Cited by 230
Tanaka, A., Moriyama, M., Nakashima, H., Miyake, K., Hayashida, J., Maehara, T., Shinozaki, S., Kubo, Y., & Nakamura, S. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33320 · Cited by 229
Immunology of IgG4-related disease
Della-Torre, E., Lanzillotta, M., & Doglioni, C. (2015) · Clinical and Experimental Immunology · doi:10.1111/cei.12641 · Cited by 226
Self-citationPredictors of disease relapse in IgG4-related disease following rituximab
Wallace, Z. S., Mattoo, H., Mahajan, V. S., Kulikova, M., Lu, L., Deshpande, V., Choi, H. K., Pillai, S., & Stone, J. H. (2016) · Rheumatology · doi:10.1093/rheumatology/kev438 · Cited by 216
Umehara, H., Okazaki, K., Nakamura, T., Satoh-Nakamura, T., Nakajima, A., Kawano, M., Mimori, T., & Chiba, T. (2017) · Modern Rheumatology · doi:10.1080/14397595.2017.1290911 · Cited by 215
Management of IgG4-related disease
Zhang, W., & Stone, J. H. (2019) · The Lancet Rheumatology · doi:10.1016/s2665-9913(19)30017-7 · Cited by 214
Akiyama, M., Suzuki, K., Yamaoka, K., Yasuoka, H., Takeshita, M., Kaneko, Y., Kondo, H., Kassai, Y., Miyazaki, T., Morita, R., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39209 · Cited by 210
Masamune, A., Nishimori, I., Kikuta, K., Tsuji, I., Mizuno, N., Iiyama, T., Kanno, A., Tachibana, Y., Ito, T., Kamisawa, T., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312049 · Cited by 205
Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016
Masamune, A., Sano, T., Takikawa, T., Matsumoto, R., Hamada, S., Abe, T., Tanaka, Y., Takeyama, Y., Kikuta, K., Japan Pancreatitis Study Group, et al. (2019) · Journal of Gastroenterology · doi:10.1007/s00535-026-02438-w · Cited by 203
Laminin 511 is a target antigen in autoimmune pancreatitis
Shiokawa, M., Kodama, Y., Sekiguchi, K., Kuwada, T., Tomono, T., Kuriyama, K., Yamazaki, H., Morita, T., Marui, S., Sogabe, Y., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aaq0997 · Cited by 195
Ebbo, M., Grados, A., Guedj, E., Gobert, D., Colavolpe, C., Zaidan, M., Masseau, A., Bernard, F., Berthelot, J., Morel, N., et al. (2014) · Arthritis Care & Research · doi:10.1002/acr.22058 · Cited by 189
Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease
Hubers, L. M., Vos, H., Schuurman, A. R., Erken, R., Oude Elferink, R. P., Burgering, B., van de Graaf, S. F. J., & Beuers, U. (2018) · Gut · doi:10.1136/gutjnl-2017-314548 · Cited by 189
Recent advances in autoimmune pancreatitis: type 1 and type 2
Kamisawa, T., Chari, S. T., Lerch, M. M., Kim, M.-H., Gress, T. M., & Shimosegawa, T. (2013) · Gut · doi:10.1136/gutjnl-2012-304224 · Cited by 188
An International Multispecialty Validation Study of the IgG4‐Related Disease Responder Index
Wallace, Z. S., Khosroshahi, A., Carruthers, M. D., Perugino, C. A., Choi, H., Campochiaro, C., Culver, E. L., Cortazar, F., Della‐torre, E., Ebbo, M., et al. (2018) · Arthritis Care & Research · doi:10.1002/acr.23543 · Cited by 185
Self-citationLesional CD4+ IFN-γ+ cytotoxic T lymphocytes in IgG4-related dacryoadenitis and sialoadenitis
Maehara, T., Mattoo, H., Ohta, M., Mahajan, V. S., Moriyama, M., Yamauchi, M., Drijvers, J., Nakamura, S., Stone, J. H., & Pillai, S. S. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209139 · Cited by 181
Akiyama, M., Yasuoka, H., Yamaoka, K., Suzuki, K., Kaneko, Y., Kondo, H., Kassai, Y., Koga, K., Miyazaki, T., Morita, R., et al. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1064-4 · Cited by 179
Culver, E. L., Sadler, R., Bateman, A. C., Makuch, M., Cargill, T., Ferry, B., Aalberse, R., Barnes, E., & Rispens, T. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.02.007 · Cited by 176
Identification of galectin-3 as an autoantigen in patients with IgG4-related disease
Perugino, C. A., AlSalem, S. B., Mattoo, H., Della-Torre, E., Mahajan, V., Ganesh, G., Allard-Chamard, H., Wallace, Z., Montesi, S. B., Kreuzer, J., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.05.011 · Cited by 176
Self-citationB lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease
Della‐Torre, E., Rigamonti, E., Perugino, C. A., Sain, S. B., Sun, N., Kaneko, N., Maehara, T., Rovati, L., Ponzoni, M., Milani, R., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.07.004 · Cited by 169
Self-citationIgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients
Campochiaro, C., Ramirez, G., Bozzolo, E., Lanzillotta, M., Berti, A., Baldissera, E., Dagna, L., Praderio, L., Scotti, R., Tresoldi, M., et al. (2016) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2015.1055796 · Cited by 163
Self-citationYunyun, F., Yu, P., Panpan, Z., Xia, Z., Linyi, P., Jiaxin, Z., Li, Z., Shangzhu, Z., Jinjing, L., Di, W., et al. (2019) · Rheumatology · doi:10.1093/rheumatology/key227 · Cited by 161
Maehara, T., Moriyama, M., Nakashima, H., Miyake, K., Hayashida, J., Tanaka, A., Shinozaki, S., Kubo, Y., & Nakamura, S. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201477 · Cited by 157
Saeki, T., & Kawano, M. (2013) · Kidney International · doi:10.1038/ki.2013.393 · Cited by 151
Pathologies Associated with Serum IgG4 Elevation
Ebbo, M., Grados, A., Bernit, E., Vely, F., Boucraut, J., Harlé, J., Daniel, L., & SCHLEINITZ, N. (2012) · International Journal of Rheumatology · doi:10.1155/2012/602809 · Cited by 151
Yamada, K., Yamamoto, M., Saeki, T., Mizushima, I., Matsui, S., Fujisawa, Y., Hara, S., Takahashi, H., Nomura, H., Kawa, S., et al. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1467-x · Cited by 150
Furukawa, S., Moriyama, M., Tanaka, A., Maehara, T., Tsuboi, H., Iizuka, M., Hayashida, J., Ohta, M., Saeki, T., Notohara, K., et al. (2014) · Clinical Immunology · doi:10.1016/j.clim.2014.10.008 · Cited by 147
Nationwide Epidemiological Survey of Autoimmune Pancreatitis in Japan
Kanno, A., Nishimori, I., Masamune, A., Kikuta, K., Hirota, M., Kuriyama, S., Tsuji, I., & Shimosegawa, T. (2012) · Pancreas · doi:10.1097/mpa.0b013e3182480c99 · Cited by 147
Fei, Y., Chen, Y., Panpan, Z., Chen, H., Wu, D., Li-dan, Z., Linyi, P., Li, W., Wu, Q., Xuan, Z., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06520-5 · Cited by 147
Della‐Torre, E., Feeney, E. R., Deshpande, V., Mattoo, H., Mahajan, V. S., Kulikova, M., Wallace, Z. S., Carruthers, M. N., Chung, R. T., Pillai, S. S., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205799 · Cited by 144
Self-citationCirculating plasmablasts/plasma cells: a potential biomarker for IgG4-related disease
Lin, W., Zhang, P., Chen, H., Chen, Y., Yang, H., Zheng, W., Zhang, X., Zhang, F., Zhang, W., & Lipsky, P. E. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1231-2 · Cited by 140
Furukawa, S., Moriyama, M., Miyake, K., Nakashima, H., Tanaka, A., Maehara, T., Iizuka-Koga, M., Tsuboi, H., Hayashida, J., Ishiguro, N., et al. (2017) · Scientific Reports · doi:10.1038/srep42413 · Cited by 134
Bledsoe, J. R., Della‐Torre, E., Rovati, L., & Deshpande, V. (2018) · Apmis · doi:10.1111/apm.12845 · Cited by 133
Self-citationSerial Changes of Elevated Serum IgG4 Levels in IgG4-related Systemic Disease
Tabata, T., Kamisawa, T., Takuma, K., Egawa, N., Setoguchi, K., Tsuruta, K., Obayashi, T., & Sasaki, T. (2011) · Internal Medicine · doi:10.2169/internalmedicine.50.4321 · Cited by 129
IgG4‐Related Disease: Retrospective Analysis of One Hundred Sixty‐Six Patients
Sekiguchi, H., Horie, R., Kanai, M., Suzuki, R., Yi, E. S., & Ryu, J. H. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39686 · Cited by 127
Kubota, K., Kamisawa, T., Okazaki, K., Kawa, S., Hirano, K., Hirooka, Y., Uchida, K., Shiomi, H., Ohara, H., Shimizu, K., et al. (2017) · Journal of Gastroenterology · doi:10.1007/s00535-016-1302-1 · Cited by 120
Della‐Torre, E., Cassione, E. B., Sciorati, C., Ruggiero, E., Lanzillotta, M., Bonfiglio, S., Mattoo, H., Perugino, C. A., Bozzolo, E. P., Rovati, L., et al. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40469 · Cited by 116
Self-citationOmar, D., Chen, Y., Cong, Y., & Dong, L. (2019) · Rheumatology · doi:10.1093/rheumatology/kez380 · Cited by 116
Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease
Campochiaro, C., Della‐Torre, E., Lanzillotta, M., Bozzolo, E. P., Baldissera, E. M., Milani, R., Arcidiacono, P. G., Crippa, S., Falconi, M., & Dagna, L. (2019) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2019.12.029 · Cited by 114
Self-citationAberrant Expansion and Function of Follicular Helper T Cell Subsets in IgG4‐Related Disease
Chen, Y., Lin, W., Yang, H., Wang, M., Zhang, P., Feng, R., Chen, H., Peng, L., Zhang, X., Zhao, Y., et al. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40556 · Cited by 113
T Cell Polarization toward TH2/TFH2 and TH17/TFH17 in Patients with IgG4-Related Disease
Grados, A., Ebbo, M., Pipéroglou, C., Groh, M., Régent, A., Samson, M., Terrier, B., Loundou, A., Morel, N., Audia, S., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00235 · Cited by 106
Analysis of IgG4 class switch-related molecules in IgG4-related disease
Tsuboi, H., Matsuo, N., Iizuka, M., et al. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3924 · Cited by 103
Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes
Lanzillotta, M., Campochiaro, C., Mancuso, G., Ramirez, G. A., Capurso, G., Falconi, M., Dagna, L., & Della‐Torre, E. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa221 · Cited by 96
Self-citationMasaki, Y., Matsui, S., Saeki, T., Tsuboi, H., Hirata, S., Izumi, Y., Miyashita, T., Fujikawa, K., Dobashi, H., Susaki, K., et al. (2016) · Modern Rheumatology · doi:10.1080/14397595.2016.1259602 · Cited by 95
IgG4-related hepatobiliary disease: an overview
Culver, E. L., & Chapman, R. W. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.132 · Cited by 93
IgG4-related disease in the Japanese population: a genome-wide association study
Terao, C., Ôta, M., Iwasaki, T., Shiokawa, M., Kawaguchi, S., Kuriyama, K., Kawaguchi, T., Kodama, Y., Yamaguchi, I., Uchida, K., et al. (2019) · The Lancet Rheumatology · doi:10.1016/s2665-9913(19)30006-2 · Cited by 93
Diagnostic Value of Serum IgG4 for IgG4-Related Disease
Hao, M., Liu, M., Fan, G., Yang, X., & Li, J. (2016) · Medicine · doi:10.1097/md.0000000000003785 · Cited by 92
Majumder, S., Mohapatra, S., Lennon, R. J., Ramos, G. P., Postier, N., Gleeson, F. C., Levy, M. J., Pearson, R. K., Petersen, B. T., Vege, S. S., et al. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.02.049 · Cited by 87
Serum BAFF and APRIL levels in patients with IgG4-related disease and their clinical significance
Kiyama, K., Kawabata, D., Hosono, Y., Kitagori, K., Yukawa, N., Yoshifuji, H., Omura, K., Fujii, T., & Mimori, T. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3810 · Cited by 75
Antineutrophil cytoplasmic antibody positivity in IgG4-related disease
Della‐Torre, E., Lanzillotta, M., Campochiaro, C., et al. (2016) · Medicine · doi:10.1097/md.0000000000004633 · Cited by 75
Self-citationMaehara, T., Mattoo, H., Mahajan, V. S., Murphy, S. J. H., Yuen, G. J., Ishiguro, N., Ohta, M., Moriyama, M., Saeki, T., Yamamoto, H., et al. (2018) · Life Science Alliance · doi:10.26508/lsa.201800050 · Cited by 74
Diagnostic value of IgG4 Indices in IgG4-Related Hypertrophic Pachymeningitis
Della‐Torre, E., Galli, L., Franciotta, D. M., Bozzolo, E. P., Briani, C., Furlan, R., Roveri, L., Sessa, M., Passerini, G., & Sabbadini, M. G. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.10.008 · Cited by 73
Self-citationProhibitin Is Involved in Patients with IgG4 Related Disease
Du, H., Shi, L., Chen, P., Yang, W., Xun, Y., Yang, C., Zhao, L., Zhou, Y., & Chen, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125331 · Cited by 73
Methotrexate for maintenance of remission in IgG4-related disease: Fig. 1
Della‐Torre, E., Campochiaro, C., Bozzolo, E. P., Dagna, L., Scotti, R., Nicoletti, R., Stone, J. H., & Sabbadini, M. G. (2015) · Rheumatology · doi:10.1093/rheumatology/kev244 · Cited by 72
Self-citationImmunoglobulin G4–related Disease
Wallace, Z. S., Perugino, C. A., Matza, M. A., Deshpande, V., Sharma, A., & Stone, J. H. (2019) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2019.05.005 · Cited by 71
Berti, A., Della‐Torre, E., Gallivanone, F., Canevari, C., Milani, R., Lanzillotta, M., Campochiaro, C., Ramirez, G. A., Cassione, E. B., Bozzolo, E. P., et al. (2017) · Lara D. Veeken · doi:10.1093/rheumatology/kex234 · Cited by 69
Self-citationPerugino, C. A., Mattoo, H., Mahajan, V. S., Maehara, T., Wallace, Z. S., Pillai, S. S., & Stone, J. H. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40168 · Cited by 67
Tomiyama, T., Uchida, K., Matsushita, M., Ikeura, T., Fukui, T., Takaoka, M., Nishio, A., & Okazaki, K. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0361-y · Cited by 66
Dupilumab as a novel steroid-sparing treatment for IgG4-related disease
Simpson, R. S., Lau, S. K. C., & Lee, J. K. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216368 · Cited by 65
Lanzillotta, M., Della‐Torre, E., Milani, R., Bozzolo, E. P., Cassione, E. B., Rovati, L., Arcidiacono, P. G., Partelli, S., Falconi, M., Ciceri, F., et al. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1718-5 · Cited by 62
Self-citationDistinct features distinguishing IgG4-related disease from multicentric Castleman's disease
Sasaki, T., Akiyama, M., Kaneko, Y., Mori, T., Yasuoka, H., Suzuki, K., Yamaoka, K., Okamoto, S., & Takeuchi, T. (2017) · RMD Open · doi:10.1136/rmdopen-2017-000432 · Cited by 58
“How I manage” IgG4-Related Disease
Della‐Torre, E., & Stone, J. H. (2016) · Journal of Clinical Immunology · doi:10.1007/s10875-016-0331-0 · Cited by 54
Self-citationLee, J.-H., Hyun, S. H., Kim, S., Kim, D., Lee, J. K., Moon, S. H., Cho, Y. S., Choe, Y. S., Kim, B., & Lee, K.-H. (2016) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001153 · Cited by 52
Cargill, T. N., Makuch, M., Sadler, R., Lighaam, L. C., Peters, R., van Ham, S. M., Klenerman, P., Bateman, A. C., Rispens, T., Barnes, E. J., et al. (2019) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000020 · Cited by 52
Liu, Y., Xue, M., Wang, Z., Zeng, Q., Ren, L., Zhang, Y., Zhang, S., Wang, Y., Shen, D., Xia, C.-S., et al. (2019) · Rheumatology · doi:10.1093/rheumatology/kez280 · Cited by 52
Buijs, J., van Heerde, M. J., Rauws, E. A. J., de Buy Wenniger, L. J. M., Hansen, B. E., Biermann, K., Verheij, J., Vleggaar, F. P., Brink, M. A., Beuers, U. H. W., et al. (2014) · Pancreas · doi:10.1097/mpa.0000000000000044 · Cited by 51
Rituximab for idiopathic and IgG4-related retroperitoneal fibrosis
Wallwork, R. S., Wallace, Z. S., Perugino, C. A., Sharma, A., & Stone, J. H. (2018) · Medicine · doi:10.1097/md.0000000000012631 · Cited by 51
The Utility of Serum IgG4 Concentrations as a Biomarker
Kawa, S., Ito, T., Watanabe, T., Maruyama, M., Hamano, H., Maruyama, M., Muraki, T., & Arakura, N. (2012) · International Journal of Rheumatology · doi:10.1155/2012/198314 · Cited by 50
Different clinical patterns of IgG4-RD patients with and without eosinophilia
Zhang, X., Zhang, P., Li, J., He, Y., Fei, Y., Peng, L., Shi, Q., Zhang, W., & Zhao, Y. (2019) · Scientific Reports · doi:10.1038/s41598-019-52847-6 · Cited by 49
Effects of glucocorticoids on B-cell subpopulations in patients with IgG4-related disease.
Lanzillotta, M., Della‐Torre, E., Milani, R., Bozzolo, E. P., Cassione, E. B., Rovati, L., Arcidiacono, P. G., Partelli, S., Falconi, M., Ciceri, F., et al. (2019) · PubMed · Cited by 38
Self-citationWang, Y., Li, K., Gao, D., Luo, G., Zhao, Y., Wang, X., Zhang, J., Jin, J., Zhao, Z., Yang, C., et al. (2017) · Internal Medicine Journal · doi:10.1111/imj.13430 · Cited by 26
Synergistic effect of IgG4 antibody and CTLs causes tissue inflammation in IgG4-related disease
Sasaki, T., Yajima, T., Shimaoka, T., Ogawa, S., Saito, T., Yamaoka, K., Takeuchi, T., & Kubo, M. (2019) · International Immunology · doi:10.1093/intimm/dxz073 · Cited by 24
Efficacy of Steroid Pulse Therapy for Autoimmune Pancreatitis Type 1: A Retrospective Study
Sugimoto, M., Takagi, T. J., Suzuki, R., Konno, N., Watanabe, K., Nakamura, J., Kikuchi, H., Waragai, Y., Asama, H., Takasumi, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138604 · Cited by 21
IL-1 family cytokines and receptors in IgG4-related disease
Capecchi, R., Italiani, P., Puxeddu, I., Pratesi, F., Tavoni, A. G., Boraschi, D., & Migliorini, P. (2017) · Cytokine · doi:10.1016/j.cyto.2017.08.001 · Cited by 21
Methotrexate as Induction of Remission Therapy for Type 1 Autoimmune Pancreatitis
Rovati, L., Lanzillotta, M., Bozzolo, E. P., Arcidiacono, P. G., Falconi, M., Dagna, L., & Della‐Torre, E. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000232 · Cited by 14
Self-citationSarnago, A., Pascual, R. M., Moreno, M. J., Laíz, B., & Fuster, Ó. (2017) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2017.09.004 · Cited by 13
Can the Practice of Retainer Medicine Improve Primary Care?
Huddle, T. S., & Centor, R. M. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-5-201203060-00024 · Cited by 8
Stone, J. H., Wallace, Z. S., Perugino, C. A., Fernandes, A., Patel, P., Foster, P., & Zack, D. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-eular.3301 · Cited by 8
Cited by
The Role of B Cells and B Cell Therapies in Immune-Mediated Liver Diseases
Cargill, T., & Culver, E. L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.661196 · Cited by 46
Metadata
- Authors
- Lanzillotta, M., Mancuso, G., & Della-Torre, E.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2020-06-16
- Volume
- 369
- Pages
- m1067
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W3035551419
- Cited by
- 360
- References
- 113
- FWCI
- 29.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.